Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.
about
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolismAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVenous thromboembolism: Predicting recurrence and the need for extended anticoagulationPredicting the risk of venous thromboembolism recurrenceReview article: Venous thromboembolism after total joint replacementDiagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice GuidelinesGuidelines on oral anticoagulation with warfarin - fourth editionReview of venous thromboembolism and race: the generalizability of treatment guidelines for high-risk populations.Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic reviewThromboembolism.Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trialsA re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism.Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis.Deep vein thromboses in users of opioid drugs: incidence, prevalence, and risk factors.Factor V leiden thrombophilia in a female collegiate soccer athlete: a case report.Predicting the future: it's not a SNP.Bilateral pulmonary emboli in a collegiate gymnast: a case reportExtended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.How to prevent, treat, and overcome current clinical challenges of VTE.Evaluation and management of chronic pulmonary thromboembolic disease.Duration of anticoagulation after cerebral venous sinus thrombosis.A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism.Optimal treatment duration of venous thrombosis.Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: Building a successful program.Large blood vessel stretch in lumbar spine through anterior surgical approach: An experimental study in adult goatAnticoagulation for venous thromboembolism.Diagnosis and anticoagulant treatment.Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.
P2860
Q24194466-F3CE649B-D707-4E73-AB20-3B43A566FE72Q24633053-8FBF0FAA-68E6-42F7-B25F-7C8847C2AAB2Q26825608-2D01C4E2-4E2C-4D15-B87B-3D4A40D2E06CQ26865059-9003D488-D845-4C38-943D-D5CA46BAE97EQ27006824-522C75BE-9AC4-4525-A3DA-146749DA57C0Q28072833-85E75C6E-37AC-46D9-AE16-1528CA46A445Q28240666-58F44A39-8B4C-401E-9D4A-2EE26FF44285Q30251792-255D4621-B38D-4F26-8710-341F18C3E6C7Q33795571-84444814-3C6A-4A98-ADC6-93B0DFAD9337Q33840400-502BC41F-5A01-4AD5-ABD1-821DEA7D90EBQ33910755-27AE7018-E745-4DCC-94A3-04D9734A9592Q33918677-E888C833-E242-4973-9D59-9C7EDA7EAB5EQ34286102-A31BD893-0E47-43A8-940E-0D41213E10DBQ35536251-C26787F8-EE48-4447-81A9-851A11669A2DQ35572246-4F039C97-38E1-4FEB-8C37-83BAC78F8019Q36849098-9DB54464-CBE3-4C03-8024-5FA919CE14ADQ37076516-92EF8B0A-4F73-49F9-87F4-2CAE461DB11FQ37416685-E3D7FC7B-3B99-4EA5-BB47-8633629B1673Q37844472-853A99BB-3166-4F5C-A0BF-559C5827AD56Q37903951-F718A25F-21D3-4145-B284-E01B2C1D946BQ37924503-C40D7084-678D-4F77-9DAA-BA6D1C576637Q37970586-C808C8BD-F53D-4635-93B1-DD5CD6A34EEAQ38002155-CB8C5DA3-05DA-4494-BA28-78E1F4E454FFQ38117732-EA34F39F-A0C2-4095-94DE-4DE30C99C484Q38382279-60793386-B7AC-4198-AF6D-7C89C2D04E73Q38630841-6AD48E40-D3A6-4B8F-9C93-A4B2B235F77FQ42876280-FD688A06-BF88-4251-81F4-70095D779347Q45847579-C41C3279-9CAB-402E-B821-E15ACEF454B9Q47402079-DA727746-D641-45C3-9207-E7821F381283
P2860
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Anticoagulation for three vers ...... sm, or both: randomised trial.
@ast
Anticoagulation for three vers ...... sm, or both: randomised trial.
@en
type
label
Anticoagulation for three vers ...... sm, or both: randomised trial.
@ast
Anticoagulation for three vers ...... sm, or both: randomised trial.
@en
prefLabel
Anticoagulation for three vers ...... sm, or both: randomised trial.
@ast
Anticoagulation for three vers ...... sm, or both: randomised trial.
@en
P2093
P2860
P1433
P1476
Anticoagulation for three vers ...... sm, or both: randomised trial.
@en
P2093
D P Bentley
H G M Shetty
I A Campbell
I J Williamson
P A Routledge
R J Prescott
P2860
P356
10.1136/BMJ.39098.583356.55
P407
P577
2007-02-08T00:00:00Z